Andres Poveda, MD Initia Oncology Hospital Quironsalud Valencia, Spain 5 Live #ASCO20
4:57
Key Insights on Final overall survival (OS) results from SOLO2/ENGOT-ov21: A phase III trial assessing maintenance olaparib in patients (pts) with platinum-sensitive, relapsed ovarian cancer and a BRCA mutation.
Gynecologic Malignancies
Andres Poveda, MD Initia Oncology Hospital Quironsalud Valencia, Spain 5 Live #ASCO20
Key Insights on Final overall survival (OS) results from SOLO2/ENGOT-ov21: A phase III trial assessing maintenance olaparib in patients (pts) with platinum-sensitive, relapsed ovarian cancer and a BRCA mutation.
Gynecologic Malignancies Similar Videos
Similar Videos
-
Elisabeth Driver, MD; Stanford Cancer Institute; 5Live #SGO22
3:36
Key Insights from the 2022 Society of Gynecologic Oncology (SGO) Annual Meeting #SGO22
-
Kathleen Moore, MD; Stephenson Cancer Center at the University of Oklahoma; 5Live; #ASCO2021
7:47
-
Ritu Salani, MD, MBA; David Geffen School of Medicine at UCLA; 5Live; #ASCO2021
4:35
